Immix Biopharma Inc. – Filings and Transcripts

NASDAQ: IMMX
Share price (6/30/26): $10.31
Market cap (6/30/26): $720 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Janus Henderson Group plc

Morris Gabriel S

News Filter

Shareholder Vote Results

Announces Pricing of $150 Million Underwritten Offering of Common Stock

Announces 95% Complete Response Rate in Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2

Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness